Literature DB >> 303995

Lysosomal enzyme inhibitors and antimetastatic activity in the mouse.

T Giraldi, C Nisi, G Sava.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 303995     DOI: 10.1016/0014-2964(77)90042-1

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN: 0014-2964            Impact factor:   9.162


× No keyword cloud information.
  8 in total

1.  The influence of the protease inhibitor aprotinin on tumor invasion of three cell lines in vitro.

Authors:  E Prange; W Schroyens; H Pralle
Journal:  Clin Exp Metastasis       Date:  1988 Mar-Apr       Impact factor: 5.150

2.  Interaction of mammalian cells with polymorphonuclear leukocytes: relative sensitivity to monolayer disruption and killing.

Authors:  I Ginsburg; D F Gibbs; J Varani
Journal:  Inflammation       Date:  1989-10       Impact factor: 4.092

3.  Effect of anti-fibrinolytic therapy on experimental melanoma metastasis.

Authors:  Jennifer M Kirstein; Kevin C Graham; Lisa T Mackenzie; Danielle E Johnston; Leslie J Martin; Alan B Tuck; Ian C MacDonald; Ann F Chambers
Journal:  Clin Exp Metastasis       Date:  2008-12-12       Impact factor: 5.150

Review 4.  Cysteine proteinases and metastasis.

Authors:  B F Sloane; K V Honn
Journal:  Cancer Metastasis Rev       Date:  1984       Impact factor: 9.264

5.  Serum activities of lysosomal enzymes in patients with liver cell carcinoma.

Authors:  N Nagasue; K Inokuchi; R Kanashima
Journal:  Dig Dis Sci       Date:  1982-05       Impact factor: 3.199

Review 6.  Glycosidases in cancer and invasion.

Authors:  R J Bernacki; M J Niedbala; W Korytnyk
Journal:  Cancer Metastasis Rev       Date:  1985       Impact factor: 9.264

Review 7.  Cell detachment and metastasis.

Authors:  L Weiss; P M Ward
Journal:  Cancer Metastasis Rev       Date:  1983       Impact factor: 9.264

8.  Endocytosis of the antiprotease aprotinin by Landschütz ascites carcinoma cells and its effects in vitro and in vivo.

Authors:  A W Thomson; D J Tweedie; R G Pugh-Humphreys; M Arthur
Journal:  Br J Cancer       Date:  1978-07       Impact factor: 7.640

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.